维普中文期刊产品整合服务
57篇 您的检索式:作者名="Kumar PG"
    题名 作者 年代 出处 被引量
1Effect of earig luteml phase administratfon of mifepristone (Eu486) on leukaemia inkibitory factor,transformimg growth factor beat and vascular endothelial growth factor in the implantation stage endometrium of the rhesus monkey显示文摘Ohosh D Kumar PG Sengupta J 1998The Journal of endocrino ogy1998,157,01:1
2Role of resistin in obesity,insulin resistance and Type II diabetes显示文摘Kusminski GM McTeman PG Kumar S 2005Clin Sci2005,109,3:1
3Effect of early luteal phase administration of mifepristone (RU486) on leukaernia inhibitory factor, transforming growth factor, beta and vascular endothelial growth factor in the implantation stage endometrium of the rhesus monkey显示文摘Ghosh D Kumar PG Sengupta J 1998J Endocrinol1998,157,1:1
4Retinol binding protein 4 and pathogenesis of diabetes 显示文摘McTernan PG Kumar S 2007J Clin Endocrinol Metab2007,92,7:1
5Synthesism spectral characterization in - vitro microbiology evaluation and cytotoxic activities of novel macrocyclicbis hydrazone 显示文摘Avaji PG Kumar CH Patil SA 2009Eur J Med Chem2009,44,9:1
6Effect of early luteal phase administration of mifepristone ( RU486 ) on leukaemia inhibitory factor,transforming growth factor beta and vascular endotheha growth factor in the implantation stage endometrium of the rhesus monkey 显示文摘Ghosh D Kumar PG Sengupta J 1998J Endocrinol1998,157,1:1
7Randomized, multicenter, phase 2 study (EVOLUTION) of combinations of bortezomib, dexamethasone, cyclophosphamide, and lenalidomide in previously untreated multiple myeloma显示文摘Kumar S Flinn 1 Richardson PG 2012Blood2012,119,19:1
8Adipokine inflammation andinsulin resistance: the role of glucose, lipids and endotoxin 显示文摘Piya MK McTeman PG Kumar S 2013J Endocrino12013,216,:1
9Effect of early luteal phase administration of mifepristone(Ru486)on leukatmia inhibitory factor,transforming growth factor beta and vascular endothelial growth factor in the implantalion stage endometrium of the rhesus monkey显示文摘Ghosh D Kumar PG Sengupta J 1998J Endocrinol1998,157,1:1
10Mifepristone ( Ru486 )antagonizes monocyte chemotactic protein-3 down-regulationat early mouse pregnancy revealing immunomodulatory e-vents in Ru486 induced abortion显示文摘Nautiyal J Kumar PG· Laloraya M 2004Am J Reprod Immunol *2004,52,1:1
11Resistin显示文摘McTernan PG Kusminski CM Kumar S 2006Curr Opin Lipidol2006,17,2:1
12Role of resistin in obesity,insu- lin resistance and Type II diabetes显示文摘Kusminski CM Mcternan PG Kumar S 2005Clin Sci (Lond)2005,109,3:1
13Randomized,multicenter,phase 2 study (EVOLUTION)of combinations of bortezomib,dexamethasone,cyclophosphamide,and lenalidomide in previously untreated multiple myeloma显示文摘Kumar S Flinn I Richecharson PG 2012{H}Blood2012,,:1
14Randomized,m ulticenter,phase 2 study (EVOLUTION) of combinations of bortezomib,dexamethasone,cyclophosphamide,and lenalidomide in previously untreated multiple myeloma显示文摘Kumar S Flinn I Richardson PG 2012Blood2012,119,19:1
15Mifepristone (Ru486) antagonizes monocyte chemotactic protein-3 down-regulation at early mouse pregnancy revealing immunomodulatory events in Ru486 induced abortion显示文摘Nautiyal J Kumar PG Laloraya M 2004Am J Reprod Immunol2004,52,1:1
16Randomized,multicenter, phase 2 study ( EVOLUTION) of combinations of bortezomib, dexamethasone, cyclophosphamide, and lenalidomide in previously untreated multiple myeloma显示文摘Kumar S Flinn I Richardson PG 2012Blood2012,119,19:1
17Mifepristone(Ru486 ) antagonizes monocyte chemotacticprotein - 3 down - regulation at early mouse preg- nancy revealing immunomodulatory events in Ru486 induced abortion 显示文摘Nautiyal J Kumar PG Laloraya M 2004Am J Reprod Immunol2004,52,1:1
18Resistin显示文摘McTernan PG Kusminski CM Kumar S 2006Curr Opin Lipidol2006,17,2:1
19Randomized, multicenter, phase 2 study (EVOLUTION) of combinations of bortezomib, dexamethasone, cyclophosphamide, and lenalidomide in previously untreated multiple myeloma显示文摘KUMAR S FLINN I RICHARDSON PG 2012Blood2012,119,19:1
20Adipokine inflammation and insulin resistance: the role of glucose, lipidsandendotoxm 显示文摘Piya MK McTernan PG Kumar S 2013J Endocrinol2013,216,1:1
返回顶部 每页显示:
共3页 首页 上一页 第1页 下一页 末页 /3 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费